Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium
J. Clin. Oncol 2023 Jan 09;[EPub Ahead of Print], DK Hansen, S Sidana, LC Peres, C Colin Leitzinger, L Shune, A Shrewsbury, R Gonzalez, DW Sborov, C Wagner, D Dima, H Hashmi, MH Kocoglu, S Atrash, G Simmons, N Kalariya, C Ferreri, A Afrough, A Kansagra, P Voorhees, R Baz, J Khouri, M Alsina, J McGuirk, FL Locke, KK PatelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.